Preparation and evaluation of99mTc-Epidermal Growth Factor Receptor (EGFR)-peptide nucleic acid for visualization of EGFR messenger RNA expression in malignant tumors

Journal of Nuclear Medicine

Volumn 55, Issue 6, 2014, Pages 1008-1016

  Zhao, Xinming ^a   Wang, Na ^a   Ren, Xiuchun ^a   Zhang, Jingmian ^a   Wang, Jianfang ^a   Han, Jingya ^a   Jia, Lizhuo ^a   Liu, Yunuan ^a   Zhang, Zhaoqi ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

EGFR; Malignant tumors; Molecular imaging; Peptide nucleic acid

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; PEPTIDE NUCLEIC ACID; TECHNETIUM 99M; TECHNETIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EPIDERMAL GROWTH FACTOR RECEPTOR GENE; FEMALE; GENE OVEREXPRESSION; IN VIVO STUDY; INTERNALIZATION; ISOTOPE LABELING; LIGAND BINDING; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR IMAGING; MOLECULAR STABILITY; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; RADIOCHEMISTRY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS; ANIMAL; BREAST NEOPLASMS; DIAGNOSTIC USE; DRUG STABILITY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KINETICS; METABOLISM; NUCLEOTIDE SEQUENCE; OVARIAN NEOPLASMS; PATHOLOGY; TISSUE DISTRIBUTION; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

ANIMALS; BASE SEQUENCE; BIOLOGICAL TRANSPORT; BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG STABILITY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOTOPE LABELING; KINETICS; MICE; OVARIAN NEOPLASMS; PEPTIDE NUCLEIC ACIDS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; TECHNETIUM; TISSUE DISTRIBUTION;

EID: 84903123013     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.113.136101     Document Type: Article

References (36)

1. Bigner SH, Burger PC, Wong AJ, et al. Gene amplification in malignant human gliomas: clinical and histopathologic aspects. J Neuropathol Exp Neurol. 1988;47:191-205.
2. Walker RA, Dearing SJ. Expression of epidermal growth factor receptor mRNA and protein in primary breast carcinomas. Breast Cancer Res Treat. 1999;53:167-176. (Pubitemid 29161123)
3. Psyrri A, Kassar M, Yu Z, et al. Effect of epidermal growth factor receptor expression level on survival in patients with epithelial ovarian cancer. Clin Cancer Res. 2005;11:8637-8643. (Pubitemid 43005911)
4. Hirsch FR, Varella-Garcia M, Bunn PA Jr, et al. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol. 2003;21:3798-3807. (Pubitemid 46606235)
5. Schlomm T, Kirstein P, Iwers L, et al. Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer. Clin Cancer Res. 2007;13:6579-6584. (Pubitemid 350206791)
6. Mendelsohn J. Blockade of receptors for growth factors: an anticancer therapy-the fourth annual Joseph H Burchenal American Association of Cancer Research Clinical Research Award Lecture. Clin Cancer Res. 2000;6:747-753. (Pubitemid 30159326)
7. Yarden Y. The EGFR family and its ligands in human cancer: signaling mechanisms and therapeutic opportunities. Eur J Cancer. 2001;37:S3-S8. (Pubitemid 32938123)
8. Ciardiello F, Tortora G. EGFR antagonists in cancer treatment. N Engl J Med. 2008;358:1160-1174.
9. Rusch V, Baselga J, Cordon-Cardo C, et al. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. Cancer Res. 1993;53:2379-2385. (Pubitemid 23156828)
10. Shao YY, Shau WY, Lin ZZ, et al. Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer. Eur J Cancer. 2013;49:106-114.
11. Fry DW, Kraker AJ, McMichael A, et al. A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science. 1994;265:1093-1095. (Pubitemid 24293076)
12. Marchetti A, Martella C, Felicioni L, et al. EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment. J Clin Oncol. 2005;23:857-865. (Pubitemid 46224186)
13. Giralt J, de las Heras M, Cerezo L, et al. The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy: a multicenter, retrospective analysis. Radiother Oncol. 2005;74:101-108. (Pubitemid 40331866)
14. Giltnane JM, Ryden L, Cregger M, et al. Quantitative measurement of epidermal growth factor receptor is a negative predictive factor for tamoxifen response in hormone receptor positive premenopausal breast cancer. J Clin Oncol. 2007;25:3007-3014. (Pubitemid 47218046)
15. Meng X, Yu JM. Detecting the epidermal growth factor receptors status in nonsmall cell lung cancer. Chin Med J (Engl). 2011;124:4324-4329.
16. Cappuzzo F, Hirsch FR, Rossi E, et al. Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small cell lung cancer. J Natl Cancer Inst. 2005;97:643-655. (Pubitemid 40812628)
17. Memon AA, Jakobsen S, Dagnaes-Hansen F, et al. Positron emission tomography (PET) Imaging with [11C]-labeled erlotinib: a micro-PET study on mice with lung tumor xenografts. Cancer Res. 2009;69:873-878.
18. 11C-PD153035 PET/CT predicts survival in non-small cell lung cancer treated with EGFR-TKI: a pilot study. J Nucl Med. 2011;52:1573-1579.
19. 18F-labeled Affibody molecule. J Nucl Med. 2012;53:1110-1118.
20. 177Lu-nimotuzumab targeting epidermal growth factor receptor overexpressing tumors. Nucl Med Biol. 2012;39:3-13.
21. Shazeeb MS, Sotak CH, DeLeo M, III, et al. Targeted signal-amplifying enzymes enhance MRI of EGFR expression in an orthotopic model of human glioma. Cancer Res. 2011;71:2230-2239.
22. Neto C, Fernandes C, Oliveira MC, et al. Radiohalogenated 4-anilinoquinazoline-based EGFR-TK inhibitors as potential cancer imaging agents. Nucl Med Biol. 2012;39:247-260.
23. Bhaumik S, Walls Z, Puttaraju M, et al. Molecular imaging of gene expression in living subjects by spliceosome-mediated RNA transsplicing. Proc Natl Acad Sci USA. 2004;101:8693-8698. (Pubitemid 38745833)
24. 111In-peptide nucleic acid antisense radiopharmaceuticals and brain drug-targeting technology. J Nucl Med. 2004;45:1766-1775.
25. 99mTc-peptide-peptide nucleic acid probes for imaging oncogene mRNAs in tumors. Nucl Med Commun. 2003;24:857-863.
26. Tian X, Aruva MR, Wolfe HR, et al. Tumor-targeting peptide-PNA-peptide chimeras for imaging overexpressed oncogene mRNAs. Nucleosides Nucleotides Nucleic Acids. 2005;24:1085-1091. (Pubitemid 41440754)
27. Mardirossian G, Lei K, Rusckowski M, et al. In vivo hybridization of technetium-99m-labeled peptide nucleic acid (PNA). J Nucl Med. 1997;38:907-913. (Pubitemid 27251983)
28. Nielsen PE, Egholm M, Berg RH, et al. Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science. 1991;254:1497-1500. (Pubitemid 21917487)
29. Demidov VV, Potaman VN, Frank-Kamenetskii MD, et al. Stability of peptide nucleic acids in human serum and cellular extracts. Biochem Pharmacol. 1994;48:1310-1313. (Pubitemid 24298385)
30. Doyle DF, Braasch DA, Simmons CG, et al. Inhibition of gene expression inside cells by peptide nucleic acids: effect of mRNA target sequence, mismatched bases, and PNA length. Biochemistry. 2001;40:53-64. (Pubitemid 32052677)
31. Stock RP, Olvera A, Sanchez R, et al. Inhibition of gene expression in Entamoeba histolytica with antisense peptide nucleic acid oligomers. Nat Biotechnol. 2001;19:231-234. (Pubitemid 32220563)
32. Metaferia B, Wei JS, Song YK, et al. Development of peptide nucleic acid probes for detection of the HER2 oncogene. PLoS ONE. 2013;8:e58870.
33. Giesen U, Kleider W, Berding C, et al. A formula for thermal stability (Tm) prediction of PNA/DNA duplexes. Nucleic Acids Res. 1998;26:5004-5006. (Pubitemid 28491183)
34. Takiya T, Seto Y, Yasuda H, et al. An empirical approach for thermal stability (Tm) prediction of PNA/DNA duplexes. Nucleic Acids Symp Ser (Oxf). 2004;48:131-132.
35. Kent WJ. BLAT: the BLAST-like alignment tool. Genome Res. 2002;12:656-664.
36. Miao Z, Ren G, Liu H, et al. Small-animal PET imaging of human epidermal growth factor receptor positive tumor with a 64Cu labeled Affibody protein. Bioconjug Chem. 2010;21:947-954.